[老年病学. 在医院. 专注于神经认知障碍]
Kristof Major1, Wanda Bosshard Taroni1, Luigia Fratangelo1
1Service de gériatrie et réadaptation gériatrique, Centre hospitalier universitaire vaudois, 1011 Lausanne.
Revue medicale suisse
|January 15, 2025
概括
神经认知障碍影响全球数百万人. 研究突出了新的治疗方法和预防策略,包括解决视力损失等危险因素,并使用抗凝血药来降低痴呆风险.
科学领域:
- 神经学 神经学
- 公共卫生 公共卫生
- 老年病的医生 老年病的医生
背景情况:
- 神经认知障碍是一个重大的全球健康问题,影响了5500万个人,预计到2050年将增加三倍.
- 包括线粒体功能障碍和脑炎症在内的病理机制是关键的研究领域.
- 可修改的风险因素,如视力丧失,强调了早期干预和预防策略的必要性.
研究的目的:
- 总结一下最近关于神经认知障碍的研究成果.
- 突出新兴的治疗方法和风险因素管理.
- 要强调一个综合战略管理这些条件的重要性.
主要方法:
- 审查关于神经认知障碍病理学的当前研究.
- 对可修改的风险因素和预防研究的分析.
- 对抗粉样蛋白治疗的临床试验数据的评估.
- 检查关于药物处方和对心房的抗凝药的流行病学数据.
主要成果:
- 线粒体功能障碍和神经炎症被确定为关键的病理机制.
- 视力丧失是需要早期预防的重大可修改风险因素.
- 瑞士的一项研究表明,老年人群中不适当的药物处方率很高.
- 抗粉样蛋白治疗方法 (lecanemab,donanemab) 显示出有希望的疗效.
- 抗凝血治疗心房动可能会降低痴呆症的风险.
结论:
- 结合治疗进步和预防措施的综合方法至关重要.
- 解决可修改的风险因素和优化药物管理是必不可少的.
- 对病理机制和治疗疗效的进一步研究是有必要的,以应对日益增长的神经认知障碍负担.
更多相关视频
相关概念视频
01:30Cognitive Development During Adulthood
49
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
49
01:22Alzheimer's Disease: Treatment
161
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
161
01:26Alzheimer's Disease: Overview
440
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
440
01:26Aging
36
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
36
01:30Dementia
94
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
94
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
95
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
95